Tag: breast cancer treatment
-
![Today’s Idea: Perimeter Medical Imaging AI (PINK.V) to Set New Standard for BCS]()
Today’s Idea: Perimeter Medical Imaging AI (PINK.V) to Set New Standard for BCS
I’ve said it before but I will say it again. Cancer is a bitch. In fact, this group of diseases is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, according to the World Health Organization (WHO). For starters, what the hell is cancer? Cancer arises from the transformation of…
-
![Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder]()
Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however, before this turns into a sob story let me assure you that my mom is alive and well after kicking cancer’s ass. My mom was diagnosed…
-
![Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases]()
Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases
In 25% of Breast Lumpectomy surgeries, cancerous material is left behind. With current technology, the surgeon needs to wait about a week, to see if he’s got all the cancerous material.
-
Perimeter Medical Imaging AI (PINK.V): the power of a simple story
No need to cut the patient open again later. The surgeon can make adjustments on the fly.
-
Perimeter Medical Imaging AI (PINK.V) shuffles the deck
PINK is accelerating toward the commercialisation of the OTIS platform. It has already received a $7.4 million grant (non-dilutive capital) from the Cancer Prevention and Research Institute of Texas (CPRIT) to fund the ATLAS AI Project.
-
Perimeter Medical Imaging AI (PINK.V) untapped value in medtech
Investing your money in health or medical companies is difficult. The complexity of the science often deters investors from allocating a portion of their portfolio to said industry, despite those companies having proven potential to provide the largest gains for its investors. We’re not criticizing – everyone knows that medical terminology is only second to…
